Lari Lehtiö, Ph.D
Affiliations: | University of Oulu, Oulu, Finland |
Area:
ADP-ribosylation: Structural & Chemical biology.Google:
"Lari Lehtiö"Mean distance: (not calculated yet)
Children
Sign in to add traineeSudarshan Narasimha Murthy | grad student | 2015-2020 | University of Oulu (Crystallography Tree) |
Yashwanth Ashok | post-doc | University of Oulu | |
Sudarshan Narasimha Murthy | post-doc | 2020-2021 | University of Oulu (Crystallography Tree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Vela-Rodríguez C, Scarpulla I, Ashok Y, et al. (2023) Discovery of DTX3L inhibitors through a homogeneous FRET-based assay that monitors formation and removal of poly-ubiquitin chains. Slas Discovery : Advancing Life Sciences R & D |
Murthy S, Nizi MG, Maksimainen MM, et al. (2023) [1,2,4]Triazolo[3,4-]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP Enzymes. Journal of Medicinal Chemistry |
Brinch SA, Amundsen-Isaksen E, Espada S, et al. (2022) The Tankyrase Inhibitor OM-153 Demonstrates Antitumor Efficacy and a Therapeutic Window in Mouse Models. Cancer Research Communications. 2: 233-245 |
Galera-Prat A, Alaviuhkola J, Alanen HI, et al. (2022) Protein engineering approach to enhance activity assays of mono-ADP-ribosyltransferases through proximity. Protein Engineering, Design & Selection : Peds |
Nizi MG, Maksimainen MM, Lehtiö L, et al. (2022) Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules. Journal of Medicinal Chemistry. 65: 7532-7560 |
Roy A, Alhammad YM, McDonald P, et al. (2022) Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening. Antiviral Research. 105344 |
Sherrill LM, Joya EE, Walker A, et al. (2022) Design, synthesis and evaluation of inhibitors of the SARS-CoV-2 nsp3 macrodomain. Bioorganic & Medicinal Chemistry. 67: 116788 |
Nizi MG, Maksimainen MM, Murthy S, et al. (2022) Potent 2,3-dihydrophthalazine-1,4-dione derivatives as dual inhibitors for mono-ADP-ribosyltransferases PARP10 and PARP15. European Journal of Medicinal Chemistry. 237: 114362 |
Sherrill LM, Joya EE, Walker A, et al. (2022) Design, Synthesis and Evaluation of Inhibitors of the SARS-CoV2 nsp3 Macrodomain. Biorxiv : the Preprint Server For Biology |
Roy A, Alhammad YM, McDonald P, et al. (2022) Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening. Biorxiv : the Preprint Server For Biology |